168 related articles for article (PubMed ID: 20536273)
21. [Hydrocortisone butyrate (Locoid) compared with betamethasone valerate. A controlled clinical trail].
Thormann J
Ugeskr Laeger; 1976 Jan; 138(4):214-6. PubMed ID: 766347
[No Abstract] [Full Text] [Related]
22. Treatment of refractory prurigo nodularis with lenalidomide.
Kanavy H; Bahner J; Korman NJ
Arch Dermatol; 2012 Jul; 148(7):794-6. PubMed ID: 22801610
[No Abstract] [Full Text] [Related]
23. Immunomodulating Agents as Antipruritics.
Erickson S; Nahmias Z; Rosman IS; Kim BS
Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
[TBL] [Abstract][Full Text] [Related]
24. [A case of systemic adverse effects after prolonged local therapy with betamethasone-17-valerate ointment].
Halsos AM
Tidsskr Nor Laegeforen; 1978 Feb; 98(4):199-200. PubMed ID: 625746
[No Abstract] [Full Text] [Related]
25. Efficacy of thalidomide in the treatment of prurigo nodularis.
Taefehnorooz H; Truchetet F; Barbaud A; Schmutz JL; Bursztejn AC
Acta Derm Venereol; 2011 May; 91(3):344-5. PubMed ID: 21279302
[No Abstract] [Full Text] [Related]
26. Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).
Tsianakas A; Zeidler C; Riepe C; Borowski M; Forner C; Gerss J; Metz M; Staubach P; Raap U; Kaatz M; Urban M; Luger TA; Ständer S
Acta Derm Venereol; 2019 Apr; 99(4):379-385. PubMed ID: 30653242
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study.
Rigopoulos D; Gregoriou S; Belyayeva E; Larios G; Kontochristopoulos G; Katsambas A
Br J Dermatol; 2009 Apr; 160(4):858-60. PubMed ID: 19120329
[TBL] [Abstract][Full Text] [Related]
28. Topical vitamin D3 (tacalcitol) for steroid-resistant prurigo.
Katayama I; Miyazaki Y; Nishioka K
Br J Dermatol; 1996 Aug; 135(2):237-40. PubMed ID: 8881666
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of evidence-based treatments for prurigo nodularis.
Qureshi AA; Abate LE; Yosipovitch G; Friedman AJ
J Am Acad Dermatol; 2019 Mar; 80(3):756-764. PubMed ID: 30261199
[TBL] [Abstract][Full Text] [Related]
30. Amitriptyline and azathioprine: an effective therapeutic approach in prurigo nodularis resistant to conventional therapies.
Briatico G; Scharf C; Di Brizzi EV; Pellerone S; Buononato D; Squadrilli F; Babino G; Argenziano G; Giorgio CM
J Dtsch Dermatol Ges; 2023 Mar; 21(3):291-293. PubMed ID: 36730609
[No Abstract] [Full Text] [Related]
31. Treatment and Burden of Disease in a Cohort of Patients with Prurigo Nodularis: A Survey-based Study.
Todberg T; Zachariae C; Skov L
Acta Derm Venereol; 2020 Apr; 100(8):adv00119. PubMed ID: 32215661
[TBL] [Abstract][Full Text] [Related]
32. The use of biodegradable microneedle patches to increase penetration of topical steroid for prurigo nodularis.
Shin JU; Kim JD; Kim HK; Kang HK; Joo C; Lee JH; Jeong DH; Song S; Chu H; Lee JS; Lee H; Lee KH
Eur J Dermatol; 2018 Feb; 28(1):71-77. PubMed ID: 29521638
[TBL] [Abstract][Full Text] [Related]
33. Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis.
Saraceno R; Nisticò SP; Capriotti E; de Felice C; Rhodes LE; Chimenti S
Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):43-5. PubMed ID: 18201357
[TBL] [Abstract][Full Text] [Related]
34. Clinical inquiries. Do nonmedicated topicals relieve childhood eczema?
Yates JE; Phifer JB; Flake D
J Fam Pract; 2009 May; 58(5):280-1. PubMed ID: 19442393
[TBL] [Abstract][Full Text] [Related]
35. A 12-month double-blind clinical comparison of betamethasone valerate and sodium chromoglycate in the treatment of asthma.
Couch AH; Sutton PH; Walker SR
Practitioner; 1977 Nov; 219(1313):751-4. PubMed ID: 413109
[No Abstract] [Full Text] [Related]
36. [Dermatologic evaluation comparing 2 local corticosteroid preparations].
Leu F
Rev Med Suisse Romande; 1976 Apr; 96(4):323-34. PubMed ID: 1006007
[No Abstract] [Full Text] [Related]
37. Non-Systemic Medication for the Treatment of Prurigo Nodularis: A Systematic Review.
Ranpariya M; Zaino ML; McCampbell LE; Patel T; Feldman SR
J Cutan Med Surg; 2024; 28(2):173-177. PubMed ID: 38291823
[TBL] [Abstract][Full Text] [Related]
38. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
39. Treatment of psoriasis: comparative study using allantoin coal tar extract combined with hydrocortisone and betamethasone valerate.
Almeyda J; Wood H
Br J Clin Pract; 1979 Apr; 33(4):106-8. PubMed ID: 475951
[No Abstract] [Full Text] [Related]
40. Betamethasone valerate treatment of steroid dependent children.
Howard K; Jacoby NM
Postgrad Med J; 1974 Sep; 50 suppl 4():41-4. PubMed ID: 4619443
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
